在患有多发性硬化症的女性患者中,用于治疗失禁的亚三角形醇注射疗法
Lancet (London, England)
|June 11, 1983
概括
在多发性硬化症患者中,亚三角注射有效地治疗了严重的冲动性失禁. 这种微创手术为83%以前药物治疗失败的女性提供了干燥的结果.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 神经学 神经学
- 盆腔健康 盆腔健康
背景情况:
- 多发性硬化症 (MS) 经常导致神经性膀功能障碍.
- 急迫性失禁和导管泄漏是MS患者的衰弱症状.
- 以前的治疗方法,包括药物治疗,往往产生不满意的结果.
研究的目的:
- 评估亚三角内注射治疗女性多发性硬化患者严重冲动失禁的疗效.
- 评估这种干预在对常规药物治疗不耐药的患者中的成功率.
主要方法:
- 包括24名患有多发性硬化和严重冲动性失禁的女性患者.
- 所有参与者都接受了亚三角形注射.
- 根据失禁状态和导管泄漏情况来评估患者的结果.
主要成果:
- 83%的患者在醇注射程序后达到干燥.
- 这种治疗在患者中取得了显著的成功,这些患者之前没有对医疗管理做出反应.
- 观察到内部尿道导管周围的泄漏减少.
结论:
- 亚三角注射是治疗多发性硬化症妇女严重冲动失禁的高效治疗方法.
- 这种微创方法为患有耐治疗症状的患者提供了可行的解决方案.
- 进一步的研究可能会探索长期疗效和患者报告的结果.
相关概念视频
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...